Systems and methods for mechanogenetic functional ultrasound imaging
US-12172037-B2 · Dec 24, 2024 · US
US8940286B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940286-B2 |
| Application number | US-201013379346-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 22, 2010 |
| Priority date | Jun 22, 2009 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method and evaluation kit are provided, in which a high-capacity urate transporter is identified to assist in the early treatment and prevention of urate transport-related disease and inflammation-related disease. The method can include a step for detecting variations in genes that encode ABCG2 protein. When a subject has an SNP of V12M, R113X, Q126X, Q141K, F208S, G268R, E334X, S441N, L447V, S486N, F506SfsX4, R575X, and/or C608X, it can be concluded that the subject has a factor that is capable of inducing urate transport failure, or a state or disease attributable to that failure. When a subject has an SNP of V12M, it can be concluded that, unlike the other SNPs, there is a possibility that the subject does not possess such a factor because, although this variation itself does not lead to a change in urate transport capability, said variation is related to linkage disequilibrium with other SNPs.
Opening claim text (preview).
The invention claimed is: 1. A high capacity urate transporter formulation, comprising: a polypeptide having (i) an amino acid sequence consisting of SEQ ID NO:62; and, (ii) a cell membrane permeating peptide; wherein, the polypeptide is a cross-linked polypeptide having the cell membrane permeating peptide linked to SEQ ID NO:62 through a cross-linking agent. 2. The formulation of claim 1 , wherein the amino acid sequence consisting of SEQ ID NO:62 is syn…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.